For Pharmaceutical & Biotech Companies
Competitive intelligence for pharma — track clinical trial landscapes, monitor competitor pipelines, and identify partnership opportunities across therapeutic areas.
Start Free TrialThe Intelligence Gaps
Pharmaceutical and biotech teams face strategic blind spots that erode competitive advantage
Clinical Trial Blind Spots
Competitor trial starts, phase transitions, and results postings happen across dozens of registries. Without continuous monitoring, you miss early signals of competing programs or emerging safety signals that affect your own development strategy.
Patent Cliff Planning
Losing exclusivity on a blockbuster creates a strategic void. Identifying pipeline assets, licensing opportunities, and partnership targets requires scanning patent filings, early-stage trials, and academic publications across therapeutic areas.
Partnership Scouting
Identifying the right biotech partner for co-development, licensing, or acquisition requires deep visibility into preclinical and clinical-stage assets, funding history, and scientific leadership — information scattered across unconnected sources.
How Our Platform Helps
Contextual Intelligence connects clinical trial registries, patent databases, funding sources, and scientific literature into a unified competitive intelligence platform designed for pharma and biotech strategists.
Our platform tracks over 600,000 active clinical trials across 240+ registries, maps patent families to therapeutic areas, and surfaces emerging science from PubMed and preprint servers — all scored by relevance to your portfolio.
Whether you are monitoring a specific competitor, scouting a new modality, or planning for patent expiry, our platform delivers the structured intelligence your team needs to act with conviction.
How It Works
From fragmented data sources to portfolio-ready competitive intelligence
Define Your Competitive Landscape
Configure your therapeutic areas, competitor companies, technology modalities, and target indications. Set relevance thresholds so every alert is immediately actionable for your pipeline strategy.
Multi-Source Signal Aggregation
Our crawlers monitor ClinicalTrials.gov, EU CTIS, WHO ICTRP, PubMed, preprint servers, USPTO, EPO, WIPO, SEC filings, and funding databases. Every new trial registration, patent filing, and publication is captured within minutes.
Portfolio Impact Analysis
Each signal is analyzed for its impact on your portfolio. A competitor's Phase II start in your lead indication triggers a higher alert than preclinical activity in a peripheral area. Signals are enriched with financial and scientific context.
Strategic Intelligence Delivery
Receive tailored intelligence briefs, competitive landscape updates, and partnership opportunity reports via your preferred channels — dashboard, Slack, email, or automated export to your BI tools.
Key Benefits
What pharma and biotech teams gain from continuous competitive intelligence
Know when competitors advance programs into your indications, file patents around your IP, or publish data that changes the standard of care.
Identify preclinical and early-stage assets months before they appear in licensing databases. Surface academic spinouts and startup biotechs with novel science aligned to your strategy.
Catch FDA and EMA guideline changes, breakthrough therapy designations, and expedited approval pathways that affect your development timeline and competitive positioning.
Sharpen Your Competitive Edge
Discover how pharma and biotech teams use our platform to protect and grow their pipelines
See Plans & Pricing